DEA Revokes Webb’s Square Pharmacy Registration Over Illegal Drug Dispensing
Estimated reading time: 4–8 minutes
On July 14, 2025, the U.S. Drug Enforcement Administration (DEA) announced that it has revoked the DEA registration of JYA LLC, also known as Webb’s Square Pharmacy, located in Davenport, Florida. This decision comes after findings that the pharmacy dispensed controlled substances without valid prescriptions and against legal requirements.
Background
On November 18, 2024, Webb’s Square Pharmacy received an Order to Show Cause and Immediate Suspension of Registration. The DEA suspended the pharmacy’s Certificate of Registration (No. FJ2231570) because it believed that keeping the pharmacy registered was an imminent danger to the public.
Hearing Process and Default
The pharmacy’s contact person received the order in person on November 21, 2024. Under the law, the pharmacy had 30 days to ask for a hearing. The DEA states that the pharmacy did not request a hearing and did not respond to the charges. Because of this, the pharmacy is considered to have admitted all the facts in the order and is in default.
Pharmacy Law and Responsibilities
Pharmacies must follow the Controlled Substances Act (CSA). The law says controlled drugs can only be dispensed for a real medical reason and with a valid prescription from a doctor. Both doctors and pharmacists are responsible for following these rules.
Florida law says a pharmacist must not fill a prescription if they believe it is not for a real medical purpose or if there is no true doctor-patient relationship. Pharmacists are supposed to check that any prescription for a controlled drug is valid and should refuse to fill it if they cannot resolve their concerns.
Facts Admitted by Pharmacy
According to the DEA, Webb’s Square Pharmacy:
- Dispensed about 312 prescriptions for controlled drugs between July 2022 and March 2024.
- Gave out controlled drugs after multiple text message conversations between the owner/pharmacist-in-charge and other parties, including a doctor and outside individuals.
- Knew or should have known that these were not legitimate prescriptions.
- Allowed third parties with no legitimate connection to patients to pick up drugs.
- Repeatedly did not attempt to check if prescriptions were real or for a valid medical purpose.
Details of Unlawful Dispensing
Some specific details include:
- In July 2022 and January 2023, the pharmacy filled multiple prescriptions for drugs like promethazine with codeine and oxycodone after arrangements between the pharmacist and a doctor, knowing the prescriptions were invalid.
- The pharmacy dispensed drugs like promethazine with codeine, alprazolam, and oxycodone for individuals who were not patients or who had no valid prescriptions.
- Prescriptions were often picked up by people with no medical relationship to the patients.
Basis for Revocation
The DEA concluded that the pharmacy violated both federal and Florida law many times by filling prescriptions it knew or should have known were not legitimate.
The DEA also found that the pharmacy did not try to defend itself or explain its actions during the official process. There was no sign the pharmacy accepted responsibility or showed it could be trusted to follow the law in the future.
Decision and Sanction
Based on these facts, the DEA decided to revoke the pharmacy’s Certificate of Registration. The agency also denied any pending applications to renew or modify this registration and any new applications for registration in Florida.
The order officially takes effect on August 13, 2025.
Authority
The order is issued under the authority of Acting DEA Administrator Robert J. Murphy and is filed by Heather Achbach, the DEA Federal Register Liaison Officer.
Reference
Federal Register, Volume 90, Number 132, Notice pages 31244-31247, Document No. 2025-13121, dated July 14, 2025.
Legal Disclaimer
This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
